Literature DB >> 26264368

A case of Fahr's disease examined by multi-modal imaging.

Ferdinando Calabria1, Gabriele Ciccariello2, Carmela Falcone3, Giuseppe Lucio Cascini4,5, Orazio Schillaci2,6.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26264368     DOI: 10.1007/s00259-015-3162-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

Review 1.  What is and what is not 'Fahr's disease'.

Authors:  Bala V Manyam
Journal:  Parkinsonism Relat Disord       Date:  2005-03       Impact factor: 4.891

2.  123I-ioflupane SPECT in Fahr disease.

Authors:  Barbara Paghera; Federico Caobelli; Raffaele Giubbini
Journal:  J Neuroimaging       Date:  2011-03-16       Impact factor: 2.486

3.  A case of intracranial meningioma detected by ¹⁸F-choline PET/CT and examined by PET/MRI fusion imaging.

Authors:  F Calabria; E Calabria; A Chiaravalloti; M Barbarisi; O Schillaci
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2014-07-10       Impact factor: 1.359

4.  The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.

Authors:  J Booij; J D Speelman; M W Horstink; E C Wolters
Journal:  Eur J Nucl Med       Date:  2001-03

5.  Psychopathological alterations in cases of symmetrical basal ganglia sclerosis.

Authors:  P König
Journal:  Biol Psychiatry       Date:  1989-02-15       Impact factor: 13.382

  5 in total
  2 in total

1.  Interest of multi-modal imaging in bilateral lesions of basal ganglia: A case report of a post-anoxic dystonia.

Authors:  Pierre-Maxime David; Nicolas Icard; Jean-Yves Gauvrit; Marc Vérin; Florence Le Jeune
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-05-13       Impact factor: 9.236

Review 2.  Basal ganglia calcifications (Fahr's syndrome): related conditions and clinical features.

Authors:  Giulia Donzuso; Giovanni Mostile; Alessandra Nicoletti; Mario Zappia
Journal:  Neurol Sci       Date:  2019-07-02       Impact factor: 3.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.